Regulations
GLOBAL
»
ICH GCP (De)
ICH GCP (En)
ICH GCP (Es)
ICH GCP (Fr)
ICH GCP (It)
ICH GCP (Pt)
ICH GCP (Ru)
USA (FDA)
UK (MHRA)
AUSTRALIA (NHMRC)
JAPAN (PMDA)
EU (EMA)
CRO List
Clinical Trials
US Clinical Trials Registry
EU Clinical Trials Registry
Pharmaceutical Companies
Clinical Research Labs
Service Companies
Clinical Research Events
Publications
Researchers
Jobs
Publications
News
ICH GCP
US Clinical Trials Registry
Search trials
Condition or disease:
Intervention/Treatment:
Sponsor:
Location:
Only recruiting and not yet recruiting studies
Search clinical trials for: 68Ga-FAPI-RGD
Total 0 results
Nothing found
Sponsors and Collaborators
Junlebao Dairy Group Co., Ltd.
Istanbul Provincial Directorate of Family and Social Services
Omer Karaca
Central Clinical Hospital RZD-Medicine, Russian Federation
City of Slagelse (municipality)
OHK Medical Devices
SAMAS Association
BioNADrx Holdings, Inc. Bryleos
The First Affiliated Hospital of Hainan Medical College
Children's Hope Alliance
Fatih University
Croatian Cooperative Group for Clinical Research in Oncology
IRCCS Fondazione Policlinico Universitario Agostino Gemelli, Milano, Italy
Healthy Drink Discoveries, Inc.
Nizam's Institute of Medical Sciences University, India
London North West Healthcare NHS Trust
OmniActive Health Technologies
Birken AG
Hengrui Therapeutics, Inc.
Matthew Modes
View Full List
Medical Conditions
People Due for Mammogram
Tru-Cut Biopsy
Improving Maternal Nutrition Knowledge
Chronotropic Incompetence
Sinonasal Malignancies
Occlusal Analysis
History of Polycystic Ovary Syndrome
BCG-Refractory Bladder Cancer
Hepatorenal Syndrome Type I
Cardiovascular Inflammation
Feeding, Complementary
Pregnancy and Thrombophilia
Genito-Urinary Neoplasm
Controlling Pain in Laparoscopic Cholecystectomy
Allogeneic Hematopoietic Cell Transplant
Receiving HD Treatment at Least 6 Months
Practice Patterns
24-hour Glucose Control
Post Concussive Symptoms
Metastatic EphA2 Positive Cancer
View Full List
Drug Interventions
AGN-199201 Dose B
Lemborexant 5 mg
Goal Directed Intravenous Restrictive Fluid Therapy
Talazoparib
Durvalumab
H2 Receptor Antagonist
Astragalus membranaceus
Fluoxetine combined with sham rTMS
Eravacycline 2mg/kg
Sublingual ketamine wafers
BYL719
BBO-10203
Capecitabine
Cyclophosphamide
Local standard venous thromboprophylaxis
Pazopanib
Selinexor+pegaspargase+dexamethasone
Fesoterodine fumarate
Copaxone®
Vehicle
View Full List
CROs by country
Contract Research Organizations in Canada
Contract Research Organizations in Djibouti
Contract Research Organizations in Finland
Contract Research Organizations in Gambia
Contract Research Organizations in Georgia
Contract Research Organizations in Lebanon
Contract Research Organizations in Mongolia
Contract Research Organizations in Norway
Contract Research Organizations in Portugal
Contract Research Organizations in Singapore
Contract Research Organizations in Sri Lanka
Contract Research Organizations in United Kingdom
Contract Research Organizations in United States
CRO list by country
CROs in Burundi
SGS
All CROs in Burundi
✕
GOOD CLINICAL PRACTICE NETWORK
Subscribe to receive notifications of regulatory updates and industry news!
Subscribe
Subscribe